U.S. federal trademark · Serial No. 79266002 · Reg. No. 6093106
Allogeneic mammalian engineered biological tissue, in particular cultivated tissue with cardiac tissue for treating cardiac insufficiency; biological cultivated cardiac tissue of stem cells for treating cardiac insufficiency; biological cultivated liver tissue intended for subsequent implantation; biological cultivated kidney tissue for medical purposes; biological cultivated brain tissue intended for subsequent implantation; biological cultivated pancreatic tissue intended for subsequent implantation; biological cultivated lung tissue intended for subsequent implantation; biological cultivated muscle tissue intended for subsequent implantation; biological cultivated gastrointestinal tissue intended for subsequent implantation; biological cultivated neuronal tissue intended for subsequent implantation; biological cultivated skin tissue intended for subsequent implantation; biological cultivated bone tissue intended for subsequent implantation; biological cultivated bone marrow intended for subsequent implantation; biological cultivated fat tissue intended for subsequent implantation; biological cultivated connective tissue or biological cultivated blood vessel tissue, all intended for subsequent implantation; Gene therapy products, namely, genetically engineered living tissues for transplant purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.